APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Non-opioid Pain Patch

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Non-opioid Pain Patch Market Outlook and Growth Opportunities 2026

Report ID 174017680420 December 2025203 pages

Choose your research edition.

Industry ResearchNon-opioid Pain Patch Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-opioid Pain Patch Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Non-opioid Pain Patch Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-opioid Pain Patch Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-opioid Pain Patch Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Non-opioid Pain Patch market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Non-opioid Pain Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Non-opioid Pain Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-opioid Pain Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Non-opioid Pain Patch market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Non-opioid Pain Patch market include Sanofi, Johnson & Johnson, Qizheng, Novartis, Mylan, Lingrui, Huarun 999, GSK and Teikoku Seiyaku, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Non-opioid Pain Patch market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Non-opioid Pain Patch and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Non-opioid Pain Patch sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Non-opioid Pain Patch market size, projected growth trends, production technologies, key applications, and end-use industries.

Non-opioid Pain Patch Segment by Company

Sanofi

Johnson & Johnson

Qizheng

Novartis

Mylan

Lingrui

Huarun 999

GSK

Teikoku Seiyaku

Nichiban

Mentholatum

Laboratoires Genevrier

Hisamitsu

Haw Par

Endo

BLUE-EMU

Actavis

Non-opioid Pain Patch Segment by Type

Fentanyl Patches

Counter-Irritant Patches

Lidocaine Patches

Diclofenac Patches

Indomethacin Patches

Others

Non-opioid Pain Patch Segment by Application

OTC

Rx

Non-opioid Pain Patch Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Non-opioid Pain Patch status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Non-opioid Pain Patch market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Non-opioid Pain Patch significant trends, drivers, influence factors in global and regions.

6. To analyze Non-opioid Pain Patch competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-opioid Pain Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-opioid Pain Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-opioid Pain Patch.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Non-opioid Pain Patch market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Non-opioid Pain Patch industry.

Chapter 3: Detailed analysis of Non-opioid Pain Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Non-opioid Pain Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Non-opioid Pain Patch in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Non-opioid Pain Patch Industry Trends Table 2. Non-opioid Pain Patch Industry Drivers Table 3. Non-opioid Pain Patch Industry Opportunities and Challenges Table 4. Non-opioid Pain Patch Industry Restraints Table 5. Global Non-opioid Pain Patch Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Non-opioid Pain Patch Revenue Share by Company (2021-2026) Table 7. Global Non-opioid Pain Patch Sales Volume by Company (M Pcs) & (2021-2026) Table 8. Global Non-opioid Pain Patch Sales Volume Share by Company (2021-2026) Table 9. Global Non-opioid Pain Patch Average Price (US$/Pcs) of Company (2021-2026) Table 10. Global Non-opioid Pain Patch Company Ranking, (2024-2026) & (USD Million) Table 11. Global Non-opioid Pain Patch Key Company Manufacturing Base & Headquarters Table 12. Global Non-opioid Pain Patch Company, Product Type & Application Table 13. Global Non-opioid Pain Patch Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Non-opioid Pain Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Fentanyl Patches Table 18. Significant Companies of Counter-Irritant Patches Table 19. Significant Companies of Lidocaine Patches Table 20. Significant Companies of Diclofenac Patches Table 21. Significant Companies of Indomethacin Patches Table 22. Significant Companies of Others Table 23. Global Non-opioid Pain Patch Sales Volume by Type 2021 VS 2025 VS 2032 (M Pcs) Table 24. Global Non-opioid Pain Patch Sales Volume by Type (2021-2026) & (M Pcs) Table 25. Global Non-opioid Pain Patch Sales Volume by Type (2027-2032) & (M Pcs) Table 26. Global Non-opioid Pain Patch Sales Volume Share by Type (2021-2026) Table 27. Global Non-opioid Pain Patch Sales Volume Share by Type (2027-2032) Table 28. Global Non-opioid Pain Patch Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Non-opioid Pain Patch Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Non-opioid Pain Patch Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Non-opioid Pain Patch Sales Value Share by Type (2021-2026) Table 32. Global Non-opioid Pain Patch Sales Value Share by Type (2027-2032) Table 33. Significant Companies of OTC Table 34. Significant Companies of Rx Table 35. Global Non-opioid Pain Patch Sales Volume by Application 2021 VS 2025 VS 2032 (M Pcs) Table 36. Global Non-opioid Pain Patch Sales Volume by Application (2021-2026) & (M Pcs) Table 37. Global Non-opioid Pain Patch Sales Volume by Application (2027-2032) & (M Pcs) Table 38. Global Non-opioid Pain Patch Sales Volume Share by Application (2021-2026) Table 39. Global Non-opioid Pain Patch Sales Volume Share by Application (2027-2032) Table 40. Global Non-opioid Pain Patch Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Non-opioid Pain Patch Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Non-opioid Pain Patch Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Non-opioid Pain Patch Sales Value Share by Application (2021-2026) Table 44. Global Non-opioid Pain Patch Sales Value Share by Application (2027-2032) Table 45. Global Non-opioid Pain Patch Sales by Region: 2021 VS 2025 VS 2032 (M Pcs) Table 46. Global Non-opioid Pain Patch Sales by Region (2021-2026) & (M Pcs) Table 47. Global Non-opioid Pain Patch Sales Market Share by Region (2021-2026) Table 48. Global Non-opioid Pain Patch Sales by Region (2027-2032) & (M Pcs) Table 49. Global Non-opioid Pain Patch Sales Market Share by Region (2027-2032) Table 50. Global Non-opioid Pain Patch Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Non-opioid Pain Patch Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Non-opioid Pain Patch Sales Value Share by Region (2021-2026) Table 53. Global Non-opioid Pain Patch Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Non-opioid Pain Patch Sales Value Share by Region (2027-2032) Table 55. Global Non-opioid Pain Patch Market Average Price (US$/Pcs) by Region (2021-2026) Table 56. Global Non-opioid Pain Patch Market Average Price (US$/Pcs) by Region (2027-2032) Table 57. Global Non-opioid Pain Patch Sales by Country: 2021 VS 2025 VS 2032 (M Pcs) Table 58. Global Non-opioid Pain Patch Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Non-opioid Pain Patch Sales by Country (2021-2026) & (M Pcs) Table 60. Global Non-opioid Pain Patch Sales Market Share by Country (2021-2026) Table 61. Global Non-opioid Pain Patch Sales by Country (2027-2032) & (M Pcs) Table 62. Global Non-opioid Pain Patch Sales Market Share by Country (2027-2032) Table 63. Global Non-opioid Pain Patch Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Non-opioid Pain Patch Sales Value Market Share by Country (2021-2026) Table 65. Global Non-opioid Pain Patch Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Non-opioid Pain Patch Sales Value Market Share by Country (2027-2032) Table 67. Sanofi Company Information Table 68. Sanofi Business Overview Table 69. Sanofi Non-opioid Pain Patch Sales (M Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 70. Sanofi Non-opioid Pain Patch Product Portfolio Table 71. Sanofi Recent Development Table 72. Johnson & Johnson Company Information Table 73. Johnson & Johnson Business Overview Table 74. Johnson & Johnson Non-opioid Pain Patch Sales (M Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 75. Johnson & Johnson Non-opioid Pain Patch Product Portfolio Table 76. Johnson & Johnson Recent Development Table 77. Qizheng Company Information Table 78. Qizheng Business Overview Table 79. Qizheng Non-opioid Pain Patch Sales (M Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 80. Qizheng Non-opioid Pain Patch Product Portfolio Table 81. Qizheng Recent Development Table 82. Novartis Company Information Table 83. Novartis Business Overview Table 84. Novartis Non-opioid Pain Patch Sales (M Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 85. Novartis Non-opioid Pain Patch Product Portfolio Table 86. Novartis Recent Development Table 87. Mylan Company Information Table 88. Mylan Business Overview Table 89. Mylan Non-opioid Pain Patch Sales (M Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 90. Mylan Non-opioid Pain Patch Product Portfolio Table 91. Mylan Recent Development Table 92. Lingrui Company Information Table 93. Lingrui Business Overview Table 94. Lingrui Non-opioid Pain Patch Sales (M Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 95. Lingrui Non-opioid Pain Patch Product Portfolio Table 96. Lingrui Recent Development Table 97. Huarun 999 Company Information Table 98. Huarun 999 Business Overview Table 99. Huarun 999 Non-opioid Pain Patch Sales (M Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 100. Huarun 999 Non-opioid Pain Patch Product Portfolio Table 101. Huarun 999 Recent Development Table 102. GSK Company Information Table 103. GSK Business Overview Table 104. GSK Non-opioid Pain Patch Sales (M Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 105. GSK Non-opioid Pain Patch Product Portfolio Table 106. GSK Recent Development Table 107. Teikoku Seiyaku Company Information Table 108. Teikoku Seiyaku Business Overview Table 109. Teikoku Seiyaku Non-opioid Pain Patch Sales (M Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 110. Teikoku Seiyaku Non-opioid Pain Patch Product Portfolio Table 111. Teikoku Seiyaku Recent Development Table 112. Nichiban Company Information Table 113. Nichiban Business Overview Table 114. Nichiban Non-opioid Pain Patch Sales (M Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 115. Nichiban Non-opioid Pain Patch Product Portfolio Table 116. Nichiban Recent Development Table 117. Mentholatum Company Information Table 118. Mentholatum Business Overview Table 119. Mentholatum Non-opioid Pain Patch Sales (M Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 120. Mentholatum Non-opioid Pain Patch Product Portfolio Table 121. Mentholatum Recent Development Table 122. Laboratoires Genevrier Company Information Table 123. Laboratoires Genevrier Business Overview Table 124. Laboratoires Genevrier Non-opioid Pain Patch Sales (M Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 125. Laboratoires Genevrier Non-opioid Pain Patch Product Portfolio Table 126. Laboratoires Genevrier Recent Development Table 127. Hisamitsu Company Information Table 128. Hisamitsu Business Overview Table 129. Hisamitsu Non-opioid Pain Patch Sales (M Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 130. Hisamitsu Non-opioid Pain Patch Product Portfolio Table 131. Hisamitsu Recent Development Table 132. Haw Par Company Information Table 133. Haw Par Business Overview Table 134. Haw Par Non-opioid Pain Patch Sales (M Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 135. Haw Par Non-opioid Pain Patch Product Portfolio Table 136. Haw Par Recent Development Table 137. Endo Company Information Table 138. Endo Business Overview Table 139. Endo Non-opioid Pain Patch Sales (M Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 140. Endo Non-opioid Pain Patch Product Portfolio Table 141. Endo Recent Development Table 142. BLUE-EMU Company Information Table 143. BLUE-EMU Business Overview Table 144. BLUE-EMU Non-opioid Pain Patch Sales (M Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 145. BLUE-EMU Non-opioid Pain Patch Product Portfolio Table 146. BLUE-EMU Recent Development Table 147. Actavis Company Information Table 148. Actavis Business Overview Table 149. Actavis Non-opioid Pain Patch Sales (M Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 150. Actavis Non-opioid Pain Patch Product Portfolio Table 151. Actavis Recent Development Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Non-opioid Pain Patch Distributors List Table 155. Non-opioid Pain Patch Customers List Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Non-opioid Pain Patch Product Image Figure 2. Global Non-opioid Pain Patch Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-opioid Pain Patch Sales Value (2021-2032) & (US$ Million) Figure 4. Global Non-opioid Pain Patch Sales (2021-2032) & (M Pcs) Figure 5. Global Non-opioid Pain Patch Sales Average Price (US$/Pcs) & (2021-2032) Figure 6. Global Non-opioid Pain Patch Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Fentanyl Patches Image Figure 10. Counter-Irritant Patches Image Figure 11. Lidocaine Patches Image Figure 12. Diclofenac Patches Image Figure 13. Indomethacin Patches Image Figure 14. Others Image Figure 15. Global Non-opioid Pain Patch Sales Volume by Type (2021 VS 2025 VS 2032) & (M Pcs) Figure 16. Global Non-opioid Pain Patch Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Non-opioid Pain Patch Sales Volume Share by Type (2021-2032) Figure 18. Global Non-opioid Pain Patch Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Non-opioid Pain Patch Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Non-opioid Pain Patch Sales Value Share by Type (2021-2032) Figure 21. OTC Image Figure 22. Rx Image Figure 23. Global Non-opioid Pain Patch Sales Volume by Application (2021 VS 2025 VS 2032) & (M Pcs) Figure 24. Global Non-opioid Pain Patch Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Non-opioid Pain Patch Sales Volume Share by Application (2021-2032) Figure 26. Global Non-opioid Pain Patch Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Non-opioid Pain Patch Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Non-opioid Pain Patch Sales Value Share by Application (2021-2032) Figure 29. Global Non-opioid Pain Patch Sales by Region: 2021 VS 2025 VS 2032 (M Pcs) Figure 30. Global Non-opioid Pain Patch Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Non-opioid Pain Patch Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Non-opioid Pain Patch Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Non-opioid Pain Patch Sales Value (2021-2032) & (US$ Million) Figure 34. North America Non-opioid Pain Patch Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Non-opioid Pain Patch Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Non-opioid Pain Patch Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Non-opioid Pain Patch Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Non-opioid Pain Patch Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Non-opioid Pain Patch Sales Value (2021-2032) & (US$ Million) Figure 40. South America Non-opioid Pain Patch Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Non-opioid Pain Patch Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Non-opioid Pain Patch Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Non-opioid Pain Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Non-opioid Pain Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Non-opioid Pain Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Non-opioid Pain Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Non-opioid Pain Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Non-opioid Pain Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Non-opioid Pain Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Non-opioid Pain Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Non-opioid Pain Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Non-opioid Pain Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Non-opioid Pain Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Non-opioid Pain Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Non-opioid Pain Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Non-opioid Pain Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Non-opioid Pain Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Non-opioid Pain Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Non-opioid Pain Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Non-opioid Pain Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Non-opioid Pain Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Non-opioid Pain Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Non-opioid Pain Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Non-opioid Pain Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Non-opioid Pain Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Non-opioid Pain Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Non-opioid Pain Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Non-opioid Pain Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Non-opioid Pain Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Non-opioid Pain Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Non-opioid Pain Patch Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Non-opioid Pain Patch Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Fentanyl Patches
  • Counter-Irritant Patches
  • Lidocaine Patches
  • Diclofenac Patches
  • Indomethacin Patches
  • Others
Applications
  • OTC
  • Rx
Companies covered
  • Sanofi
  • Johnson & Johnson
  • Qizheng
  • Novartis
  • Mylan
  • Lingrui
  • Huarun 999
  • GSK
  • Teikoku Seiyaku
  • Nichiban
  • Mentholatum
  • Laboratoires Genevrier
  • Hisamitsu
  • Haw Par
  • Endo
  • BLUE-EMU
  • Actavis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Non-opioid Pain Patch Sales Value (2021-2032)
  4. 1.2.2 Global Non-opioid Pain Patch Sales Volume (2021-2032)
  5. 1.2.3 Global Non-opioid Pain Patch Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Non-opioid Pain Patch Market Dynamics
  1. 2.1 Non-opioid Pain Patch Industry Trends
  2. 2.2 Non-opioid Pain Patch Industry Drivers
  3. 2.3 Non-opioid Pain Patch Industry Opportunities and Challenges
  4. 2.4 Non-opioid Pain Patch Industry Restraints
3 Non-opioid Pain Patch Market by Company
  1. 3.1 Global Non-opioid Pain Patch Company Revenue Ranking in 2025
  2. 3.2 Global Non-opioid Pain Patch Revenue by Company (2021-2026)
  3. 3.3 Global Non-opioid Pain Patch Sales Volume by Company (2021-2026)
  4. 3.4 Global Non-opioid Pain Patch Average Price by Company (2021-2026)
  5. 3.5 Global Non-opioid Pain Patch Company Ranking (2024-2026)
  6. 3.6 Global Non-opioid Pain Patch Company Manufacturing Base and Headquarters
  7. 3.7 Global Non-opioid Pain Patch Company Product Type and Application
  8. 3.8 Global Non-opioid Pain Patch Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Non-opioid Pain Patch Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Non-opioid Pain Patch Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Non-opioid Pain Patch Market by Type
  1. 4.1 Non-opioid Pain Patch Type Introduction
  2. 4.1.1 Fentanyl Patches
  3. 4.1.2 Counter-Irritant Patches
  4. 4.1.3 Lidocaine Patches
  5. 4.1.4 Diclofenac Patches
  6. 4.1.5 Indomethacin Patches
  7. 4.1.6 Others
  8. 4.2 Global Non-opioid Pain Patch Sales Volume by Type
  9. 4.2.1 Global Non-opioid Pain Patch Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Non-opioid Pain Patch Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Non-opioid Pain Patch Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Non-opioid Pain Patch Sales Value by Type
  13. 4.3.1 Global Non-opioid Pain Patch Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Non-opioid Pain Patch Sales Value by Type (2021-2032)
  15. 4.3.3 Global Non-opioid Pain Patch Sales Value Share by Type (2021-2032)
5 Non-opioid Pain Patch Market by Application
  1. 5.1 Non-opioid Pain Patch Application Introduction
  2. 5.1.1 OTC
  3. 5.1.2 Rx
  4. 5.2 Global Non-opioid Pain Patch Sales Volume by Application
  5. 5.2.1 Global Non-opioid Pain Patch Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Non-opioid Pain Patch Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Non-opioid Pain Patch Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Non-opioid Pain Patch Sales Value by Application
  9. 5.3.1 Global Non-opioid Pain Patch Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Non-opioid Pain Patch Sales Value by Application (2021-2032)
  11. 5.3.3 Global Non-opioid Pain Patch Sales Value Share by Application (2021-2032)
6 Non-opioid Pain Patch Regional Sales and Value Analysis
  1. 6.1 Global Non-opioid Pain Patch Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Non-opioid Pain Patch Sales by Region (2021-2032)
  3. 6.2.1 Global Non-opioid Pain Patch Sales by Region: 2021-2026
  4. 6.2.2 Global Non-opioid Pain Patch Sales by Region (2027-2032)
  5. 6.3 Global Non-opioid Pain Patch Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Non-opioid Pain Patch Sales Value by Region (2021-2032)
  7. 6.4.1 Global Non-opioid Pain Patch Sales Value by Region: 2021-2026
  8. 6.4.2 Global Non-opioid Pain Patch Sales Value by Region (2027-2032)
  9. 6.5 Global Non-opioid Pain Patch Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Non-opioid Pain Patch Sales Value (2021-2032)
  12. 6.6.2 North America Non-opioid Pain Patch Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Non-opioid Pain Patch Sales Value (2021-2032)
  15. 6.7.2 Europe Non-opioid Pain Patch Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Non-opioid Pain Patch Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Non-opioid Pain Patch Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Non-opioid Pain Patch Sales Value (2021-2032)
  21. 6.9.2 South America Non-opioid Pain Patch Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Non-opioid Pain Patch Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Non-opioid Pain Patch Sales Value Share by Country, 2025 VS 2032
7 Non-opioid Pain Patch Country-level Sales and Value Analysis
  1. 7.1 Global Non-opioid Pain Patch Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Non-opioid Pain Patch Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Non-opioid Pain Patch Sales by Country (2021-2032)
  4. 7.3.1 Global Non-opioid Pain Patch Sales by Country (2021-2026)
  5. 7.3.2 Global Non-opioid Pain Patch Sales by Country (2027-2032)
  6. 7.4 Global Non-opioid Pain Patch Sales Value by Country (2021-2032)
  7. 7.4.1 Global Non-opioid Pain Patch Sales Value by Country (2021-2026)
  8. 7.4.2 Global Non-opioid Pain Patch Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Non-opioid Pain Patch Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Non-opioid Pain Patch Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Non-opioid Pain Patch Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Non-opioid Pain Patch Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Non-opioid Pain Patch Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Non-opioid Pain Patch Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Non-opioid Pain Patch Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Non-opioid Pain Patch Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Non-opioid Pain Patch Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Non-opioid Pain Patch Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Non-opioid Pain Patch Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Non-opioid Pain Patch Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Non-opioid Pain Patch Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Non-opioid Pain Patch Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Non-opioid Pain Patch Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Non-opioid Pain Patch Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Non-opioid Pain Patch Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Non-opioid Pain Patch Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Non-opioid Pain Patch Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Non-opioid Pain Patch Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Non-opioid Pain Patch Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Non-opioid Pain Patch Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Non-opioid Pain Patch Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Non-opioid Pain Patch Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Non-opioid Pain Patch Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Non-opioid Pain Patch Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Non-opioid Pain Patch Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Non-opioid Pain Patch Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Non-opioid Pain Patch Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Non-opioid Pain Patch Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Non-opioid Pain Patch Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Non-opioid Pain Patch Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Non-opioid Pain Patch Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Non-opioid Pain Patch Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Qizheng
  14. 8.3.1 Qizheng Company Information
  15. 8.3.2 Qizheng Business Overview
  16. 8.3.3 Qizheng Non-opioid Pain Patch Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Qizheng Non-opioid Pain Patch Product Portfolio
  18. 8.3.5 Qizheng Recent Developments
  19. 8.4 Novartis
  20. 8.4.1 Novartis Company Information
  21. 8.4.2 Novartis Business Overview
  22. 8.4.3 Novartis Non-opioid Pain Patch Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Novartis Non-opioid Pain Patch Product Portfolio
  24. 8.4.5 Novartis Recent Developments
  25. 8.5 Mylan
  26. 8.5.1 Mylan Company Information
  27. 8.5.2 Mylan Business Overview
  28. 8.5.3 Mylan Non-opioid Pain Patch Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Mylan Non-opioid Pain Patch Product Portfolio
  30. 8.5.5 Mylan Recent Developments
  31. 8.6 Lingrui
  32. 8.6.1 Lingrui Company Information
  33. 8.6.2 Lingrui Business Overview
  34. 8.6.3 Lingrui Non-opioid Pain Patch Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Lingrui Non-opioid Pain Patch Product Portfolio
  36. 8.6.5 Lingrui Recent Developments
  37. 8.7 Huarun 999
  38. 8.7.1 Huarun 999 Company Information
  39. 8.7.2 Huarun 999 Business Overview
  40. 8.7.3 Huarun 999 Non-opioid Pain Patch Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Huarun 999 Non-opioid Pain Patch Product Portfolio
  42. 8.7.5 Huarun 999 Recent Developments
  43. 8.8 GSK
  44. 8.8.1 GSK Company Information
  45. 8.8.2 GSK Business Overview
  46. 8.8.3 GSK Non-opioid Pain Patch Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 GSK Non-opioid Pain Patch Product Portfolio
  48. 8.8.5 GSK Recent Developments
  49. 8.9 Teikoku Seiyaku
  50. 8.9.1 Teikoku Seiyaku Company Information
  51. 8.9.2 Teikoku Seiyaku Business Overview
  52. 8.9.3 Teikoku Seiyaku Non-opioid Pain Patch Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Teikoku Seiyaku Non-opioid Pain Patch Product Portfolio
  54. 8.9.5 Teikoku Seiyaku Recent Developments
  55. 8.10 Nichiban
  56. 8.10.1 Nichiban Company Information
  57. 8.10.2 Nichiban Business Overview
  58. 8.10.3 Nichiban Non-opioid Pain Patch Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Nichiban Non-opioid Pain Patch Product Portfolio
  60. 8.10.5 Nichiban Recent Developments
  61. 8.11 Mentholatum
  62. 8.11.1 Mentholatum Company Information
  63. 8.11.2 Mentholatum Business Overview
  64. 8.11.3 Mentholatum Non-opioid Pain Patch Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Mentholatum Non-opioid Pain Patch Product Portfolio
  66. 8.11.5 Mentholatum Recent Developments
  67. 8.12 Laboratoires Genevrier
  68. 8.12.1 Laboratoires Genevrier Company Information
  69. 8.12.2 Laboratoires Genevrier Business Overview
  70. 8.12.3 Laboratoires Genevrier Non-opioid Pain Patch Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Laboratoires Genevrier Non-opioid Pain Patch Product Portfolio
  72. 8.12.5 Laboratoires Genevrier Recent Developments
  73. 8.13 Hisamitsu
  74. 8.13.1 Hisamitsu Company Information
  75. 8.13.2 Hisamitsu Business Overview
  76. 8.13.3 Hisamitsu Non-opioid Pain Patch Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Hisamitsu Non-opioid Pain Patch Product Portfolio
  78. 8.13.5 Hisamitsu Recent Developments
  79. 8.14 Haw Par
  80. 8.14.1 Haw Par Company Information
  81. 8.14.2 Haw Par Business Overview
  82. 8.14.3 Haw Par Non-opioid Pain Patch Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Haw Par Non-opioid Pain Patch Product Portfolio
  84. 8.14.5 Haw Par Recent Developments
  85. 8.15 Endo
  86. 8.15.1 Endo Company Information
  87. 8.15.2 Endo Business Overview
  88. 8.15.3 Endo Non-opioid Pain Patch Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Endo Non-opioid Pain Patch Product Portfolio
  90. 8.15.5 Endo Recent Developments
  91. 8.16 BLUE-EMU
  92. 8.16.1 BLUE-EMU Company Information
  93. 8.16.2 BLUE-EMU Business Overview
  94. 8.16.3 BLUE-EMU Non-opioid Pain Patch Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 BLUE-EMU Non-opioid Pain Patch Product Portfolio
  96. 8.16.5 BLUE-EMU Recent Developments
  97. 8.17 Actavis
  98. 8.17.1 Actavis Company Information
  99. 8.17.2 Actavis Business Overview
  100. 8.17.3 Actavis Non-opioid Pain Patch Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Actavis Non-opioid Pain Patch Product Portfolio
  102. 8.17.5 Actavis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Non-opioid Pain Patch Value Chain Analysis
  2. 9.1.1 Non-opioid Pain Patch Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Non-opioid Pain Patch Sales Mode & Process
  6. 9.2 Non-opioid Pain Patch Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Non-opioid Pain Patch Distributors
  9. 9.2.3 Non-opioid Pain Patch Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst